CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 86 enrolled
Drug / intervention
Active TMS +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03651700
NCT03651700Phase 2Completed

A Phase II, Randomized Blinded Study of the Effects of Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for the Treatment of Chronic Aphasia

H. Branch Coslett·interventional·Posted Aug 29, 2018·Updated Oct 14, 2025

In Brief

A Phase 2 clinical trial evaluating Active TMS, Sham TMS, and 1 other intervention for Aphasia. Completed, enrolled 86 participants across 1 site.

Detailed Summary

Transcranial Magnetic Stimulation (TMS) has been demonstrated to improve language function in subjects with chronic aphasia in a number of small studies, many of which did not include a control group. Although the treatment appears promising, data to date do not permit an adequate assessment of the utility of the technique. The investigators propose to study the effects of TMS combined with Constraint Induced Language Therapy (CILT) in 75 subjects with chronic aphasia. Subjects will be randomized in a 2:1 ratio to TMS with CILT or sham TMS with CILT. One Hz TMS at 90% motor threshold will be delivered to the right inferior frontal gyrus for 20 minutes in 10 sessions over 2 weeks; language therapy will be provided for one hour immediately after the conclusion of each session of TMS. Change from baseline in the Western Aphasia Battery Aphasia Quotient at 6 months after the end of TMS treatment will serve as the primary outcome measure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphasia
CountriesUnited States

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedAug 29, 2018
Enrollment StartMar 28, 2019
Primary CompletionAug 31, 2024
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 7.8 years ago

Interventions

Active TMSdevice

Active TMS will be at 90% motor threshold

Sham TMSdevice

Sham TMS will be administered

CILTbehavioral

60-90 minutes of CILT will be administered during each treatment session